Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
31
LFST Quote, Financials, Valuation and Earnings
Last price:
$4.42
Seasonality move
:
-3.28%
Day range:
$4.33 - $4.46
52-week range:
$4.33 - $8.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.31x
P/B ratio:
1.17x
Volume:
2.1M
Avg. volume:
2.3M
1-year change:
-22.26%
Market cap:
$1.7B
Revenue:
$1.3B
EPS (TTM):
-$0.10
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LFST
LifeStance Health Group
|
$345.1M | $0.03 | 11.21% | -95.93% | $8.50 |
|
BKD
Brookdale Senior Living
|
$817.6M | -$0.14 | 4.88% | -13.75% | $7.70 |
|
ENSG
Ensign Group
|
$1.2B | $1.55 | 17.69% | 27.21% | $166.00 |
|
PACS
PACS Group
|
$1.1B | $0.47 | 16.26% | 25.31% | $30.50 |
|
PNTG
Pennant Group
|
$210.6M | $0.27 | 24.62% | 48.61% | $32.80 |
|
SGRY
Surgery Partners
|
$817M | $0.14 | 7.29% | 31.79% | $31.36 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LFST
LifeStance Health Group
|
$4.40 | $8.50 | $1.7B | -- | $0.00 | 0% | 1.31x |
|
BKD
Brookdale Senior Living
|
$7.77 | $7.70 | $1.8B | -- | $0.00 | 0% | 0.56x |
|
ENSG
Ensign Group
|
$139.85 | $166.00 | $8B | 26.44x | $0.06 | 0.18% | 1.85x |
|
PACS
PACS Group
|
$12.35 | $30.50 | $1.9B | 20.01x | $0.00 | 0% | 0.54x |
|
PNTG
Pennant Group
|
$23.76 | $32.80 | $819M | 31.26x | $0.00 | 0% | 1.05x |
|
SGRY
Surgery Partners
|
$22.64 | $31.36 | $2.9B | -- | $0.00 | 0% | 0.90x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LFST
LifeStance Health Group
|
15.94% | 0.855 | 10.67% | 1.32x |
|
BKD
Brookdale Senior Living
|
96.71% | -0.881 | 294.12% | 0.54x |
|
ENSG
Ensign Group
|
6.99% | 0.779 | 1.99% | 1.32x |
|
PACS
PACS Group
|
46.18% | 0.462 | 10.9% | 1.57x |
|
PNTG
Pennant Group
|
14.74% | 0.862 | 5.93% | 1.14x |
|
SGRY
Surgery Partners
|
67.11% | 0.533 | 72.6% | 1.40x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LFST
LifeStance Health Group
|
$109.8M | $1.6M | -2.07% | -2.48% | 0.48% | -$10.3M |
|
BKD
Brookdale Senior Living
|
$223.1M | $31.4M | -5.66% | -86.4% | -0.67% | -$18.4M |
|
ENSG
Ensign Group
|
$188.1M | $101.4M | 16.28% | 17.64% | 9.26% | $29.3M |
|
PACS
PACS Group
|
$153.9M | $710K | -- | -- | -0.33% | -$76.7M |
|
PNTG
Pennant Group
|
$29.4M | $12.7M | 8.55% | 10.97% | 6% | -$23.2M |
|
SGRY
Surgery Partners
|
$161.9M | $89.6M | -2.86% | -5.45% | 7.98% | -$16.7M |
LifeStance Health Group vs. Competitors
-
Which has Higher Returns LFST or BKD?
Brookdale Senior Living has a net margin of 0.21% compared to LifeStance Health Group's net margin of -7.98%. LifeStance Health Group's return on equity of -2.48% beat Brookdale Senior Living's return on equity of -86.4%.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.97% -- $1.7B BKDBrookdale Senior Living27.41% -$0.28 $4.5B -
What do Analysts Say About LFST or BKD?
LifeStance Health Group has a consensus price target of $8.50, signalling upside risk potential of 93.18%. On the other hand Brookdale Senior Living has an analysts' consensus of $7.70 which suggests that it could fall by -0.9%. Given that LifeStance Health Group has higher upside potential than Brookdale Senior Living, analysts believe LifeStance Health Group is more attractive than Brookdale Senior Living.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group5 1 0 BKDBrookdale Senior Living2 1 0 -
Is LFST or BKD More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Brookdale Senior Living has a beta of 0.828, suggesting its less volatile than the S&P 500 by 17.157%.
-
Which is a Better Dividend Stock LFST or BKD?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Brookdale Senior Living offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeStance Health Group pays -- of its earnings as a dividend. Brookdale Senior Living pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFST or BKD?
LifeStance Health Group quarterly revenues are $333M, which are smaller than Brookdale Senior Living quarterly revenues of $813.9M. LifeStance Health Group's net income of $709K is higher than Brookdale Senior Living's net income of -$65M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while Brookdale Senior Living's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 1.31x versus 0.56x for Brookdale Senior Living. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group1.31x -- $333M $709K BKDBrookdale Senior Living0.56x -- $813.9M -$65M
-
Which has Higher Returns LFST or ENSG?
Ensign Group has a net margin of 0.21% compared to LifeStance Health Group's net margin of 6.84%. LifeStance Health Group's return on equity of -2.48% beat Ensign Group's return on equity of 17.64%.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.97% -- $1.7B ENSGEnsign Group16.04% $1.37 $2.1B -
What do Analysts Say About LFST or ENSG?
LifeStance Health Group has a consensus price target of $8.50, signalling upside risk potential of 93.18%. On the other hand Ensign Group has an analysts' consensus of $166.00 which suggests that it could grow by 18.7%. Given that LifeStance Health Group has higher upside potential than Ensign Group, analysts believe LifeStance Health Group is more attractive than Ensign Group.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group5 1 0 ENSGEnsign Group4 1 0 -
Is LFST or ENSG More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ensign Group has a beta of 1.031, suggesting its more volatile than the S&P 500 by 3.088%.
-
Which is a Better Dividend Stock LFST or ENSG?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ensign Group offers a yield of 0.18% to investors and pays a quarterly dividend of $0.06 per share. LifeStance Health Group pays -- of its earnings as a dividend. Ensign Group pays out 4.59% of its earnings as a dividend. Ensign Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LFST or ENSG?
LifeStance Health Group quarterly revenues are $333M, which are smaller than Ensign Group quarterly revenues of $1.2B. LifeStance Health Group's net income of $709K is lower than Ensign Group's net income of $80.3M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while Ensign Group's PE ratio is 26.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 1.31x versus 1.85x for Ensign Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group1.31x -- $333M $709K ENSGEnsign Group1.85x 26.44x $1.2B $80.3M
-
Which has Higher Returns LFST or PACS?
PACS Group has a net margin of 0.21% compared to LifeStance Health Group's net margin of -1.11%. LifeStance Health Group's return on equity of -2.48% beat PACS Group's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.97% -- $1.7B PACSPACS Group15.67% -$0.07 $1.1B -
What do Analysts Say About LFST or PACS?
LifeStance Health Group has a consensus price target of $8.50, signalling upside risk potential of 93.18%. On the other hand PACS Group has an analysts' consensus of $30.50 which suggests that it could grow by 146.96%. Given that PACS Group has higher upside potential than LifeStance Health Group, analysts believe PACS Group is more attractive than LifeStance Health Group.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group5 1 0 PACSPACS Group3 0 0 -
Is LFST or PACS More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison PACS Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock LFST or PACS?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PACS Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeStance Health Group pays -- of its earnings as a dividend. PACS Group pays out 71.23% of its earnings as a dividend. PACS Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LFST or PACS?
LifeStance Health Group quarterly revenues are $333M, which are smaller than PACS Group quarterly revenues of $981.8M. LifeStance Health Group's net income of $709K is higher than PACS Group's net income of -$10.9M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while PACS Group's PE ratio is 20.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 1.31x versus 0.54x for PACS Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group1.31x -- $333M $709K PACSPACS Group0.54x 20.01x $981.8M -$10.9M
-
Which has Higher Returns LFST or PNTG?
Pennant Group has a net margin of 0.21% compared to LifeStance Health Group's net margin of 3.71%. LifeStance Health Group's return on equity of -2.48% beat Pennant Group's return on equity of 10.97%.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.97% -- $1.7B PNTGPennant Group14% $0.22 $375.5M -
What do Analysts Say About LFST or PNTG?
LifeStance Health Group has a consensus price target of $8.50, signalling upside risk potential of 93.18%. On the other hand Pennant Group has an analysts' consensus of $32.80 which suggests that it could grow by 38.05%. Given that LifeStance Health Group has higher upside potential than Pennant Group, analysts believe LifeStance Health Group is more attractive than Pennant Group.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group5 1 0 PNTGPennant Group2 2 0 -
Is LFST or PNTG More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pennant Group has a beta of 1.512, suggesting its more volatile than the S&P 500 by 51.208%.
-
Which is a Better Dividend Stock LFST or PNTG?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pennant Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeStance Health Group pays -- of its earnings as a dividend. Pennant Group pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFST or PNTG?
LifeStance Health Group quarterly revenues are $333M, which are larger than Pennant Group quarterly revenues of $209.8M. LifeStance Health Group's net income of $709K is lower than Pennant Group's net income of $7.8M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while Pennant Group's PE ratio is 31.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 1.31x versus 1.05x for Pennant Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group1.31x -- $333M $709K PNTGPennant Group1.05x 31.26x $209.8M $7.8M
-
Which has Higher Returns LFST or SGRY?
Surgery Partners has a net margin of 0.21% compared to LifeStance Health Group's net margin of -4.86%. LifeStance Health Group's return on equity of -2.48% beat Surgery Partners's return on equity of -5.45%.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.97% -- $1.7B SGRYSurgery Partners20.86% -$0.30 $7.1B -
What do Analysts Say About LFST or SGRY?
LifeStance Health Group has a consensus price target of $8.50, signalling upside risk potential of 93.18%. On the other hand Surgery Partners has an analysts' consensus of $31.36 which suggests that it could grow by 38.53%. Given that LifeStance Health Group has higher upside potential than Surgery Partners, analysts believe LifeStance Health Group is more attractive than Surgery Partners.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group5 1 0 SGRYSurgery Partners8 3 0 -
Is LFST or SGRY More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Surgery Partners has a beta of 1.896, suggesting its more volatile than the S&P 500 by 89.589%.
-
Which is a Better Dividend Stock LFST or SGRY?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Surgery Partners offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeStance Health Group pays -- of its earnings as a dividend. Surgery Partners pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFST or SGRY?
LifeStance Health Group quarterly revenues are $333M, which are smaller than Surgery Partners quarterly revenues of $776M. LifeStance Health Group's net income of $709K is higher than Surgery Partners's net income of -$37.7M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while Surgery Partners's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 1.31x versus 0.90x for Surgery Partners. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group1.31x -- $333M $709K SGRYSurgery Partners0.90x -- $776M -$37.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
